Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health problems news

Show

From To
Drugs before sex more common in UK than in Europe or US – study

UK citizens are more likely than Europeans or those living in the US to have taken drugs such as MDMA and cocaine before sex during the last year, according to a new study.

Published
02 April 2019
From
The Guardian
World’s First HIV-To-HIV Kidney Transplant With Living Donor Succeeds

The world’s first kidney transplant from a living HIV-positive donor to another HIV-positive person was successfully performed Monday by doctors at a Johns Hopkins University hospital.

Published
29 March 2019
From
Kaiser Health News
Atlanta woman becomes country's first HIV+ living kidney donor

If you ask Nina Martinez why she has fought so hard to become the first HIV + living kidney donor, her answer is pretty simple. "I just wanted to be just like anybody else," Martinez says. "I think, in 2019, this is going to blow a lot of peoples' minds. Because I'm sitting here today, as someone living for 35 years with HIV, and I'm about to donate this organ."

Published
29 March 2019
From
FOX 5 Atlanta
Study: AIDS-immunocompromised populations see more antibiotic-resistant infections

Populations with a high prevalence of AIDS-immunocompromised people are more likely to see the emergence of antibiotic-resistant bacterial infections, according to a study coauthored by researchers at the University of Tennessee, Knoxville, and published in PLOS One.

Published
27 March 2019
From
Eurekalert Inf Dis
Effect of Depression, Lifestyle on Cognitive Function in PLWHIV

Compared with patients without HIV, the poorer cognitive performances of PLWHIV were partly mediated by a higher prevalence of depressive symptoms.

Published
26 March 2019
From
Infectious Disease Advisor
On-Demand PrEP With TDF/FTC Not Associated With Clinically Relevant Decline in Kidney Function

On-demand pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) is not associated with a significant relevant in kidney function, especially among young people with low pill use and high baseline estimated glomerular filtration rate, investigators in France found.

Published
20 March 2019
From
Contagion Live
TB CAB statement on safety of using bedaquiline and delamanid together

he Global TB Community Advisory Board (TB CAB) welcomes the important finding from the AIDS Clinical Trials Group Deliberate Trial that newer drugs bedaquiline and delamanid are safe to use together. These findings should erase any remaining reluctance to use these two important drugs together, as the benefits of these safer drugs outweigh the risks--especially for patients with drug-resistant TB who have few other treatment options.

Published
14 March 2019
From
TB Online
Large French study examines neuropsychiatric side effects with integrase inhibitors

The largest prospective study to date on integrase inhibitors and their potential for being associated with neuropsychiatric side effects was conducted in France. With more than 21,000 HIV-positive participants, the study found that the proportion of people who stopped taking integrase inhibitors due to neuropsychiatric side effects was generally very low (between 1% and 3%). Of particular note is the fact that before starting treatment with an integrase-inhibitor-containing regimen, between 3% and 10% of participants had previously reported neuropsychiatric side effects with other classes of HIV treatment.

Published
12 March 2019
From
CATIE
'Patient No. 1' from a Hep C heart transplant study shares his story

By the time three transplant physicians approached Tom Giangiulio Jr. about being the first patient in a new clinical trial to accept a heart from a Hepatitis C-positive donor, Giangiulio didn’t have much of a choice.

Published
08 March 2019
From
Cardiovascular Business
Experts tackle major cardiovascular issues in treating patients with HIV

Since the advent of effective antiretroviral therapy (ART), HIV infection has become more like a chronic illness. Now that patients are able to live longer and remain free of developing AIDS, they have begun to encounter new risks from age-related disorders common in the general population, including cardiovascular disease (CVD).

Published
05 March 2019
From
EurekAlert!

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.